Abbott Laboratories (ABT)

NYSE - NYSE Real Time Price. Currency in USD
42.02-0.81 (-1.89%)
At close: 4:01 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close42.83
Bid41.97 x 200
Ask42.09 x 300
Day's Range41.93 - 42.98
52wk Range36.00 - 46.38
1y Target EstN/A
Market Cap61.77B
P/E Ratio (ttm)27.74
Avg Vol (3m)10,383,138
Dividend & Yield1.04 (2.40%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Reuters3 hours ago

    Alere lawsuit accuses Abbott of 'buyer's remorse' in proposed merger

    Alere claims in its complaint that Abbott has avoided responding to a second request by the Federal Trade Commission in a bout of "buyer's remorse" spurred by a desire to free up capital for Abbott's other major planned deal - a $24 billion acquisition of rival St. Jude Medical (STJ.N). Abbott denied the allegations, arguing that Alere's financial problems and related delays in filing its financial statements had slowed the deal's progress. Abbott also said it had been approached by a whistleblower who alleges that Alere is deliberately hiding information about its Indian operations.

  • Bloomberg3 hours ago

    Abbott Should Have Heeded Its Inner Voice

    It can't say it didn't know there were issues with its troubled takeover target.

  • TheStreet.com6 hours ago

    Alere (ALR) Stock Lower, Says Abbott Has 'Buyer's Remorse' Over Deal

    In a newly unsealed lawsuit, Alere (ALR) claims that Abbott (ABT) blocked the companies' $7.9 billion merger once it experienced 'buyer's remorse.'